Marsha Fanucci
Director/Board Member at SYROS PHARMACEUTICALS, INC.
Net worth: 46 005 $ as of 2024-03-30
Profile
Marsha H.
Fanucci is currently a Director at FORMA Therapeutics, Inc., a Director at The Schwartz Center for Compassionate Healthcare, and an Independent Director at Syros Pharmaceuticals, Inc. She previously held positions as Chairman at Cyclerion Therapeutics, Inc., Independent Director at Momenta Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and Chief Financial Officer & Senior Vice President at Millennium Pharmaceuticals, Inc. She also served as Vice President at Genzyme Corp.
and Arthur D.
Little, Inc. Fanucci holds an MBA from Northeastern University and an undergraduate degree from West Virginia University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-05-31 | 4,800 ( 0.02% ) | 25 680 $ | 2024-03-30 | |
| 2023-05-17 | 136 ( 0.00% ) | 20 325 $ | 2024-03-30 |
Marsha Fanucci active positions
| Companies | Position | Start |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Director/Board Member | 2015-10-18 |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Director/Board Member | 2014-01-31 |
| The Schwartz Center for Compassionate Healthcare | Director/Board Member | - |
Former positions of Marsha Fanucci
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Director/Board Member | 2023-09-28 |
| FORMA THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 2022-10-13 |
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 2019-03-31 |
| MOMENTA PHARMACEUTICALS, INC. | Director/Board Member | 2016-12-30 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2008-12-31 |
Training of Marsha Fanucci
| Northeastern University | Masters Business Admin |
| West Virginia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
| The Schwartz Center for Compassionate Healthcare |
- Stock Market
- Insiders
- Marsha Fanucci
